6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0015 770-24-4-801-0619 -National CMOP F0608 FERROUS SULFATE
ID: 36C77025Q0015Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/548f38a2308c4337a678d71ede54084f/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an urgent procurement of Ferrous Sulfate pharmaceuticals, specifically 324mg enteric-coated tablets, to be delivered to multiple Consolidated Mail Outpatient Pharmacies (CMOP). The procurement requires a total of 20,400 tablets across various packaging quantities, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and federal regulations. This acquisition is critical for ensuring the health and well-being of veterans who rely on these essential medications. Interested parties must submit their quotations by October 11, 2024, at 9:00 AM Central Time, including a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Trade Agreements Certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0015_1.docx
    The document outlines a requisition (36C77025Q0015) for pharmaceuticals by the Department of Veterans Affairs (VA). The solicitation encourages offers from contractors, detailing requirements for pricing, delivery, and compliance with federal regulations. It specifies that the procurement is set aside for small businesses and outlines the expected delivery schedules to multiple VA CMOP facilities. Each shipment must comply with strict regulations on packaging, labeling (including barcodes), and the Drug Supply Chain Security Act (DSCSA). Vendors are required to submit offers electronically, which must include specific documentation (such as a pricing schedule and trade agreements). The contract incorporates several federal acquisition regulations, and emphasizes the importance of quality control, particularly in relation to drug recalls. There are clear guidelines on invoicing and payments via electronic methods. The purpose of this document is to facilitate the procurement of pharmaceuticals in a compliant, efficient manner that ensures the health and well-being of veterans. Overall, it serves as a comprehensive and structured guide for obtaining pharmaceutical supplies for VA pharmacy needs.
    36C77025Q0015.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for an urgent procurement of Ferrous Sulfate pharmaceuticals to be delivered to multiple Consolidated Mail Outpatient Pharmacies (CMOP). The solicitation number is 36C77025Q0015 with a response deadline of October 11, 2024, at 9:00 AM Central Time. The requirement encompasses various quantities of Ferrous Sulfate 324mg enteric-coated tablets, with a total of 20,400 tablets across different packages. The opportunity is classified as 'unrestricted', allowing all vendors to participate. Interested parties must provide a detailed price schedule in Excel format, along with proof of state wholesale distributor licensure and compliance with the Drug Supply Chain Security Act (DSCSA). Responses should be submitted via email to the designated contact, Contract Specialist Michael W. McAlhaney. The procurement is associated with the World Trade Organization Government Procurement Agreement, highlighting a preference for U.S.-made products. Overall, this notice reveals the VA's commitment to acquiring essential pharmaceuticals efficiently while ensuring compliance with legal and regulatory standards.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The document outlines the Trade Agreements Certificate, ensuring that offerors certify the products they provide under government contracts are either U.S.-made or from designated countries, aligning with trade regulations and the Federal Acquisition Regulation (FAR). It stipulates that except for listed exceptions, all end products must meet U.S. or designated country criteria. Any products not meeting these requirements must be enumerated, noting their country of origin. The government evaluates offers based on the WTO Government Procurement Agreement (GPA), allowing for U.S. and designated countries' products to be considered without the constraints of the Buy American statute. Ultimately, only eligible offers will be awarded unless no suitable options exist. This certification process is integral to federal procurement, ensuring compliance with trade agreements and priorities for domestic products in government contracts.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0015.xlsx
    The document outlines a Request for Quotation (RFQ) from the VA for the procurement of Ferrous Sulfate 324MG EC Tablets, with an estimated issuance date of October 4, 2024, and a closing date of October 11, 2024. The RFQ specifies the quantity and packaging of the items required, and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), mandating that all suppliers submit proper documentation reflecting compliance. Offers must include a state wholesale distributor license, signed solicitation cover page, price schedule in Excel format, and a completed trade agreements certificate. The delivery deadline is set for October 31, 2024, within ten days after receipt of the order. The document provides specific contact emails for procurement, outlines multiple ship-to addresses for various CMOP locations, and reinforces the necessity for submissions to comply with drug regulatory standards. This RFQ illustrates the government's commitment to adhering to strict supply chain regulations while fulfilling pharmaceutical needs.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0014 770-24-4-801-0617 -National CMOP A1222 ACAMPROSATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure Acamprosate Calcium 333mg EC tablets through an emergency solicitation, identified by the number 36C77025Q0014, for delivery to multiple locations within its Consolidated Mail Outpatient Pharmacy (CMOP) system. The procurement requires various quantities of the specified pharmaceutical, with a total of six different delivery amounts outlined, and adherence to the Drug Supply Chain Security Act is mandatory for all vendors. This acquisition is critical for ensuring that the VA can meet its pharmaceutical needs efficiently, supporting the health and well-being of veterans. Interested vendors must submit their quotes by October 10, 2024, at 9:00 AM CST, and are encouraged to contact Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov for further details.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30-count bottles. The Request for Proposal (RFP) outlines specific requirements for offerors, including pricing for a base year and four optional one-year periods, compliance with federal regulations, and the provision of unique National Drug Code (NDC) numbers. This procurement is crucial for ensuring a reliable supply of essential medications to support veterans and related healthcare providers under the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. Interested parties must submit their proposals by October 8, 2024, at 2:30 PM Central Standard Time, and can direct inquiries to Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Bupropion Hydrochloride tablets to support veterans and related entities through its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with a strong emphasis on participation from small and disadvantaged businesses. Interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details regarding submission requirements and deadlines.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement aims to secure pharmaceutical products essential for the healthcare of veterans, specifically focusing on the manufacturing of these tablets. Norethindrone is a critical medication used in various treatments, highlighting the importance of reliable supply in supporting veteran health services. Interested vendors should note that the offer due date has been extended to October 15, 2024, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    8145--Medication Return Envelopes (VA-24-00012799)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.
    6505-- Duplex Antibiotic Supply IV Bags
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting quotes for Duplex Antibiotic Supply IV Bags under solicitation number 36C26225Q0028, aiming to establish a base contract for one year with four additional option years. The procurement requires the successful contractor to supply specific pharmaceutical products, including Cefazolin and Ceftriaxone, ensuring that all items meet the specified performance and regulatory standards. This contract is crucial for maintaining essential supplies for patient care within the VA healthcare system, with an estimated total contract value ranging from $150,000 to $300,000. Interested vendors must be registered in the System for Award Management (SAM) and submit any questions via email to Melissa Ramirez by October 8, 2024, with quotes due by October 11, 2024.
    R706--Reverse pharmaceutical distribution services. Questions and Answers for solicitation RFQ 36C26024Q0959 clarification Amendment 0001
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide reverse pharmaceutical distribution services under solicitation RFQ 36C26024Q0959. The primary objective of this procurement is to ensure the safe and compliant disposal of pharmaceutical products, including the management of liquidation-eligible and ineligible items, while adhering to federal regulations. This contract, valued at approximately $16.5 million, will span five years from November 1, 2024, to October 31, 2029, with responses due by October 10, 2024, at 13:00 Pacific Time. Interested vendors should direct inquiries to José Ronstadt at jose.ronstadt@va.gov or call 360-852-9885 for further clarification.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ketoconazole 2% Cream, which will serve various federal healthcare services, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The procurement aims to ensure an uninterrupted supply of this pharmaceutical product, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 62,643 tubes of 15 GM, 233,385 tubes of 30 GM, and 139,890 tubes of 60 GM. Interested vendors should note that the solicitation is expected to be released around October 10, 2024, with a response deadline of October 24, 2024, and can direct inquiries to Michael Olszewski at michael.olszewski@va.gov.